ScoreWhy is Cachet Pharmaceutical Co., Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -5.53% and Operating profit at -25.27% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 12.08% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -5.53% and Operating profit at -25.27% over the last 5 years
3
Flat results in Mar 26
- INVENTORY TURNOVER RATIO(HY) Lowest at 6.79 times
- RAW MATERIAL COST(Y) Grown by 15.38% (YoY)
- NET SALES(Q) Lowest at CNY 3,972.18 MM
4
With ROE of 1.78%, it has a fair valuation with a 0.84 Price to Book Value
- Over the past year, while the stock has generated a return of -15.41%, its profits have fallen by -72%
- At the current price, the company has a high dividend yield of 1.3
5
Below par performance in long term as well as near term
- Along with generating -15.41% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Cachet Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Cachet Pharmaceutical Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Cachet Pharmaceutical Co., Ltd.
-9.36%
-0.04
40.44%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-5.53%
EBIT Growth (5y)
-25.27%
EBIT to Interest (avg)
4.70
Debt to EBITDA (avg)
1.45
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
3.20
Tax Ratio
68.43%
Dividend Payout Ratio
30.12%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.71%
ROE (avg)
12.08%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
0.73
EV to EBIT
11.11
EV to EBITDA
6.57
EV to Capital Employed
0.72
EV to Sales
0.16
PEG Ratio
NA
Dividend Yield
1.54%
ROCE (Latest)
6.46%
ROE (Latest)
1.78%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,376.6 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -17.84 %
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -5.65% (YoY
PRE-TAX PROFIT(Q)
At CNY 102.9 MM has Grown at 66.16%
NET PROFIT(Q)
At CNY 48.69 MM has Grown at 88.5%
-8What is not working for the Company
ROCE(HY)
Lowest at 2.06%
NET SALES(Q)
At CNY 4,306.01 MM has Fallen at -8.48%
Here's what is working for Cachet Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 1,376.6 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Lowest at -17.84 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Pre-Tax Profit
At CNY 102.9 MM has Grown at 66.16%
over average net sales of the previous four periods of CNY 61.93 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 48.69 MM has Grown at 88.5%
over average net sales of the previous four periods of CNY 25.83 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Raw Material Cost
Fallen by -5.65% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Cachet Pharmaceutical Co., Ltd.
Net Sales
At CNY 4,306.01 MM has Fallen at -8.48%
over average net sales of the previous four periods of CNY 4,704.85 MMMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Footer loading
